QSAR Studies of Non-Nucleoside Reverse Transcriptase Inhibitors: The Hydrophobic Effect

E-ISSN： 1875-6697|2|1|21-29

ISSN： 1573-4099

Source： Current Computer - Aided Drug Design, Vol.2, Iss.1, 2006-03, pp. : 21-29

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Non-nucleoside inhibitors of HIV-1 reverse transcriptase

By Proudfoot J.R.

Expert Opinion on Therapeutic Patents, Vol. 8, Iss. 8, 1998-08 ,pp. : 971-982

Informa Healthcare

Access to resources Recommend Favorite

Clinical Pharmacokinetics of Non-Nucleoside Reverse Transcriptase Inhibitors

By Smith P.F.

Clinical Pharmacokinetics, Vol. 40, Iss. 12, 2001-01 ,pp. : 893-905

Adis International

Access to resources Recommend Favorite

HIV-1 non-nucleoside reverse transcriptase inhibitors

By Högberg M. Morrison I.

Expert Opinion on Therapeutic Patents, Vol. 10, Iss. 8, 2000-08 ,pp. : 1189-1199

Informa Healthcare

Access to resources Recommend Favorite

Pharmacokinetic drug interactions with non-nucleoside reverse transcriptase inhibitors

By Ma Qing Okusanya Olanrewaju O Smith Patrick F DiCenzo Robert Slish Judianne C Catanzaro Linda M Forrest Alan Morse Gene D

Expert Opinion on Drug Metabolism and Toxicology, Vol. 1, Iss. 3, 2005-10 ,pp. : 473-485

Informa Healthcare

Access to resources Recommend Favorite

The Role of Non-Nucleoside Reverse Transcriptase Inhibitors in Children with HIV-1 Infection

By Maddocks S. Dwyer D.

Pediatric Drugs, Vol. 3, Iss. 9, 2001-01 ,pp. : 681-702

Adis International

Access to resources Recommend Favorite